Prognostic Value of an m⁵C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma

References

• SiegelRL, MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• WangJ, LiX, WuX, et al. Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: a Bayesian network analysis. EBioMedicine. 2019;47:78–88. doi:10.1016/j.ebiom.2019.08.006.31439476
   PubMed Web of Science ®Google Scholar
• HakimiAA, VossMH, KuoF, et al. Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III Trial. Cancer Discov. 2019;9(4):510–525. doi:10.1158/2159-8290.cd-18-095730622105
   PubMed Web of Science ®Google Scholar
• MotzerRJ, JonaschE, AgarwalN, et al. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(6):804–834. doi:10.6004/jnccn.2017.010028596261
   PubMed Web of Science ®Google Scholar
• LiJK, ChenC, LiuJY, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16(1):111. doi:10.1186/s12943-017-0681-0.28659173
   PubMed Web of Science ®Google Scholar
• SunZ, JingC, XiaoC, LiT. Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma. Front Oncol. 2020;10:1430. doi:10.3389/fonc.2020.0143032974157
   PubMed Web of Science ®Google Scholar
• MiaoD, MargolisCA, GaoW, et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science. 18;359(6377):801–806. doi:10.1126/science.aan5951
   PubMed Web of Science ®Google Scholar
• HeC. Grand challenge commentary: RNA epigenetics?Nat Chem Biol. 2010;6(12):863–865. doi:10.1038/nchembio.48221079590
   PubMed Web of Science ®Google Scholar
• CaoQ, ManiRS, AteeqB, et al. Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell. 2011;20(2):187–199. doi:10.1016/j.ccr.2011.06.01621840484
   PubMed Web of Science ®Google Scholar
• HussainS, AleksicJ, BlancoS, DietmannS, FryeM. Characterizing 5-methylcytosine in the mammalian epitranscriptome. Genome Biol. 2013;14(11):215. doi:10.1186/gb414324286375
   PubMed Web of Science ®Google Scholar
• SquiresJE, PatelHR, NouschM, et al. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012;40(11):5023–5033. doi:10.1093/nar/gks14422344696
   PubMed Web of Science ®Google Scholar
• TrixlL, LusserA. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip Rev RNA. 2019;10(1):e1510. doi:10.1002/wrna.151030311405
   PubMed Web of Science ®Google Scholar
• BohnsackKE, HöbartnerC, BohnsackMT. Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: mechanisms, Cellular Functions, and Links to Disease. Genes. 2019;10(2):102. doi:10.3390/genes10020102
   PubMed Web of Science ®Google Scholar
• HuangT, ChenW, LiuJ, GuN, ZhangR. Genome-wide identification of mRNA 5-methylcytosine in mammals. Nat Struct Mol Biol. 2019;26(5):380–388. doi:10.1038/s41594-019-0218-x31061524
   PubMed Web of Science ®Google Scholar
• NombelaP, Miguel-LópezB, BlancoS. The role of m(6)A, m(5)C and Ψ RNA modifications in cancer: novel therapeutic opportunities. Mol Cancer. 2021;20(1):18. doi:10.1186/s12943-020-01263-w33461542
   PubMed Web of Science ®Google Scholar
• LiY, LiJ, LuoM, et al. Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma. Cancer Lett. 18;430:57–66. doi:10.1016/j.canlet.2018.05.013
   PubMed Web of Science ®Google Scholar
• WangF, YuanJH, WangSB, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 2014;60(4):1278–1290. doi:10.1002/hep.2723925043274
   PubMed Web of Science ®Google Scholar
• TomczakK, CzerwińskaP, WiznerowiczM. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19(1a):A68–77. doi:10.5114/wo.2014.47136
   Google Scholar
• von MeringC, HuynenM, JaeggiD, SchmidtS, BorkP, SnelB. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258–261. doi:10.1093/nar/gkg03412519996
   PubMed Web of Science ®Google Scholar
• WilkersonMD, HayesDN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq17020427518
   PubMed Web of Science ®Google Scholar
• WickhamH. Ggplot2: Elegant Graphics for Data Analysis. New York, USA; 2009.
   Google Scholar
• ZhouY, ZhouB, PacheL, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-630944313
   PubMed Web of Science ®Google Scholar
• SubramanianA, TamayoP, MoothaVK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.050658010216199517
   PubMed Web of Science ®Google Scholar
• SunY, XuZ, JiangJ, XuT, XuJ, LiuP. High Expression of Succinate Dehydrogenase Subunit A Which Is Regulated by Histone Acetylation, Acts as a Good Prognostic Factor of Multiple Myeloma Patients. Front Oncol. 2020;10:563666. doi:10.3389/fonc.2020.56366633014881
   PubMed Web of Science ®Google Scholar
• WangP, WuM, TuZ, et al. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma. Front Oncol. 2020;10:1119. doi:10.3389/fonc.2020.0111932974125
   PubMed Web of Science ®Google Scholar
• SunZ, JingC, XiaoC, LiT, WangY. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma. Aging. 2020;12(21):22078–22094. doi:10.18632/aging.10405333177247
   PubMedGoogle Scholar
• Gama-SosaMA, SlagelVA, TrewynRW, et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 1983;11(19):6883–6894. doi:10.1093/nar/11.19.68836314264
   PubMed Web of Science ®Google Scholar
• DaiX, GonzalezG, LiL, et al. YTHDF2 Binds to 5-Methylcytosine in RNA and Modulates the Maturation of Ribosomal RNA. Anal Chem. 2020;92(1):1346–1354. doi:10.1021/acs.analchem.9b0450531815440
   PubMed Web of Science ®Google Scholar
• ChenK, ZhangJ, GuoZ, et al. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer. Cell Res. 2016;26(1):103–18. doi:10.1038/cr.2015.15026680004
   PubMed Web of Science ®Google Scholar
• XiangS, MaY, ShenJ, et al. m(5)C RNA Methylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer. Front Mol Biosci. 2020;7:599340. doi:10.3389/fmolb.2020.59934033365328
   PubMed Web of Science ®Google Scholar
• SunZ, XueS, XuH, et al. Expression profiles of long noncoding RNAs associated with the NSUN2 gene in HepG2 cells. Mol Med Rep. 2019;19(4):2999–3008. doi:10.3892/mmr.2019.998430816500
   PubMed Web of Science ®Google Scholar
• ZhuQ, ZhongAL, HuH, et al. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. J Hematol Oncol. 2020;13(1):2. doi:10.1186/s13045-019-0840-431900208
   PubMed Web of Science ®Google Scholar
• ChiaS, LowJL, ZhangX, et al. Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.. Nat Commun. 2017;8(1):435. doi:10.1038/s41467-017-00451-528874669
   PubMed Web of Science ®Google Scholar
• XueM, ShiQ, ZhengL, LiQ, YangL, ZhangY. Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma. Am J Transl Res. 2020;12(10):6841–6852.33194076
   PubMed Web of Science ®Google Scholar
• SunL, LiuWK, DuXW, et al. Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma. Ann Transl Med. 2020;8(12):751. doi:10.21037/atm-20-374432647676
   PubMed Web of Science ®Google Scholar
• SaijoY, SatoG, UsuiK, et al. Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma. Ann Oncol. 2001;12(8):1121–1125. doi:10.1023/a:101161770799911583194
   PubMed Web of Science ®Google Scholar
• FreemanJW, McGrathP, BondadaV, et al. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma. Cancer Res. 1991;51(8):1973–1978.1672621
   PubMed Web of Science ®Google Scholar
• SunF, WuK, YaoZ, et al. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer. Aging. 2020;12(12):11500–11516. doi:10.18632/aging.10323632554858
   PubMedGoogle Scholar
• PerlakyL, ValdezBC, BuschRK, et al. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res. 1992;52(2):428–436.1728415
   PubMed Web of Science ®Google Scholar
• UchiyamaB, SaijoY, KumanoN, et al. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. Clin Cancer Res. 1997;3(10):1873–1877.9815576
   PubMed Web of Science ®Google Scholar
• MetodievMD, SpåhrH, Loguercio PolosaP, et al. NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly. PLoS Genet. 2014;10(2):e1004110. doi:10.1371/journal.pgen.100411024516400
   PubMed Web of Science ®Google Scholar
• SelmiT, HussainS, DietmannS, et al. Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6. Nucleic Acids Res. 2021;49(2):1006–1022. doi:10.1093/nar/gkaa119333330931
   PubMed Web of Science ®Google Scholar
• WangZL, LiB, LuoYX, et al. Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers. Cell Rep. 18;22(1):286–298. doi:10.1016/j.celrep.2017.12.035
   PubMed Web of Science ®Google Scholar
• LiC, WangS, XingZ, et al. A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19(2):106–119. doi:10.1038/ncb346428114269
   PubMed Web of Science ®Google Scholar
• NeriF, DettoriD, IncarnatoD, et al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene. 2015;34(32):4168–4176. doi:10.1038/onc.2014.35625362856
   PubMed Web of Science ®Google Scholar
• JinZ, FengH, LiangJ, et al. FGFR3(Δ7-9) promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma. Cell Death Dis. 2020;11(10):903. doi:10.1038/s41419-020-03089-233097695
   PubMed Web of Science ®Google Scholar
• XuYP, LvL, LiuY, et al. Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J Clin Invest. 2019;129(10):4316–4331. doi:10.1172/jci12931731310587
   PubMed Web of Science ®Google Scholar